Baudax Bio, Inc.
BXRXQ
$0.00
$0.000.00%
OTC PK
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | 310.00K | 238.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | 310.00K | 238.00K |
| Cost of Revenue | -- | -- | -- | 4.79M | -- |
| Gross Profit | -- | -- | -- | -4.48M | -- |
| SG&A Expenses | 3.64M | 2.25M | 1.77M | 2.09M | 2.95M |
| Depreciation & Amortization | -- | -- | -- | 65.00K | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.54M | 4.03M | 4.69M | 7.99M | 3.58M |
| Operating Income | -5.54M | -4.03M | -4.69M | -7.68M | -3.58M |
| Income Before Tax | -1.89M | -7.30M | -7.39M | -9.25M | -4.09M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.89M | -7.30M | -7.39M | -9.25M | -4.09M |
| Earnings from Discontinued Operations | -43.00K | -74.00K | 18.79M | -- | -25.12M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.93M | -7.38M | 11.40M | -9.25M | -29.21M |
| EBIT | -5.54M | -4.03M | -4.69M | -7.68M | -3.58M |
| EBITDA | -5.41M | -4.03M | -4.69M | -7.64M | -3.57M |
| EPS Basic | -0.30 | -1.51 | 4.92 | -12.33 | -98.70 |
| Normalized Basic EPS | -0.16 | -0.92 | -1.99 | -7.19 | -8.63 |
| EPS Diluted | -0.30 | -1.51 | 4.92 | -12.33 | -98.70 |
| Normalized Diluted EPS | -0.16 | -0.92 | -1.99 | -7.19 | -8.63 |
| Average Basic Shares Outstanding | 7.99M | 4.89M | 2.32M | 750.10K | 295.90K |
| Average Diluted Shares Outstanding | 7.99M | 4.89M | 2.32M | 750.10K | 295.90K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |